| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:2801.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the MRC Clinical Sciences Centre (C.A., J.S.A., A.S., C.F.H.), Faculty of Medicine, Imperial College, Hammersmith Hospital, Du Cane Road, London, UK; the Department of Vascular Surgery (S.S., A.H.D., R.G.J.G.), Faculty of Medicine, Imperial College, Charing Cross Hospital, Fulham Palace Road, London, UK. Current affiliation for C.A. is Physiology Weihenstephan, Technical University Munich, Weihenstephaner Berg 3, Freising, Germany.
Correspondence to Dr Richard Gibbs, Department of Vascular Surgery, Imperial College, Charing Cross Hospital, Fulham Palace Road, London W6 8RF. E-mail r.gibbs{at}ic.ac.uk
Background and Purpose The ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol efflux from cells, a key process in reverse cholesterol transport. Whereas previous investigations focused on mutations causing impaired ABCA1 function, we assessed the role of ABCA1 in human carotid atherosclerotic disease.
Methods We compared the mRNA and protein levels of ABCA1, and one of its key regulators, the liver X receptor
(LXR
), between minimally and grossly atherosclerotic arterial tissue. We established ABCA1 and LXR
gene expression by real-time quantitative polymerase chain reaction in 10 control and 18 atherosclerotic specimens. Presence of ABCA1 protein was assessed by immunoblotting. To determine whether differences observed at a local level were reflected in the systemic circulation, we measured ABCA1 mRNA in leukocytes of 10 patients undergoing carotid endarterectomy and 10 controls without phenotypic atherosclerosis.
Results ABCA1 and LXR
gene expression were significantly elevated in atherosclerotic plaques (P<0.0001 and 0.03, respectively). The increased mRNA levels of ABCA1 and LXR
were correlated in atherosclerotic tissue (r=0.85; P<0.0001). ABCA1 protein expression was significantly reduced in plaques compared with control tissues (P<0.0001). There were no differences in leukocyte ABCA1 mRNA expression (P=0.67).
Conclusions ABCA1 gene and protein are expressed in minimally atherosclerotic human arteries. Despite significant upregulation of ABCA1 mRNA, possibly mediated via LXR
, ABCA1 protein is markedly reduced in advanced carotid atherosclerotic lesions. No differences in leukocyte ABCA1 expression were found, suggesting the plaque microenvironment may contribute to the differential ABCA1 expression. We propose that the decreased level of ABCA1 protein is a key factor in the development of atherosclerotic lesions.
Key Words: atherosclerosis ATP binding cassette transporter 1 carotid artery plaque carotid arteries polymerase chain reaction
This article has been cited by other articles:
![]() |
O. Mani, M. T. Sorensen, K. Sejrsen, R. M. Bruckmaier, and C. Albrecht Differential expression and localization of lipid transporters in the bovine mammary gland during the pregnancy-lactation cycle J Dairy Sci, August 1, 2009; 92(8): 3744 - 3756. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Choi, M. Rahmani, B. W. Wong, S. Allahverdian, B. M. McManus, J. G. Pickering, T. Chan, and G. A. Francis ATP-Binding Cassette Transporter A1 Expression and Apolipoprotein A-I Binding Are Impaired in Intima-Type Arterial Smooth Muscle Cells Circulation, June 30, 2009; 119(25): 3223 - 3231. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Paul, H. H. D. Meyer, K. Leidl, S. Soumian, and C. Albrecht A novel enzyme immunoassay specific for ABCA1 protein quantification in human tissues and cells J. Lipid Res., October 1, 2008; 49(10): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al. ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo J. Lipid Res., June 1, 2008; 49(6): 1254 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Tansley, B. L. Burgess, M. T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J. Y. Chan, A. Wilkinson, J. Evans, K. E. Naus, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein J. Lipid Res., May 1, 2007; 48(5): 1022 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Farke, E. Viturro, H. H. D. Meyer, and C. Albrecht Identification of the bovine cholesterol efflux regulatory protein ABCA1 and its expression in various tissues J Anim Sci, November 1, 2006; 84(11): 2887 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Eck, R. R. Singaraja, D. Ye, R. B. Hildebrand, E. R. James, M. R. Hayden, and T. J.C. Van Berkel Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 929 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Soumian, R Gibbs, A Davies, and C Albrecht mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease J. Clin. Pathol., December 1, 2005; 58(12): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Soumian, C Albrecht, A. Davies, and R. Gibbs ABCA1 and atherosclerosis Vascular Medicine, May 1, 2005; 10(2): 109 - 119. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |